JPY4,260.00
0.30% today
Tokyo, Dec 24, 07:04 am CET
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Eisai Stock price

JPY4,258.00
-395.00 8.49% 1M
-2,231.00 34.38% 6M
-2,794.00 39.62% YTD
-2,730.00 39.07% 1Y
-2,311.00 35.18% 3Y
-3,979.00 48.31% 5Y
-460.00 9.75% 10Y
Tokyo, Closing price Tue, Dec 24 2024
-15.00 0.35%
ISIN
JP3160400002
Symbol
4523
Index
Sector
Industry

Key metrics

Market capitalization JPY1.19t
Enterprise Value JPY1.12t
P/E (TTM) P/E ratio 29.82
EV/FCF (TTM) EV/FCF 57.91
EV/Sales (TTM) EV/Sales 1.49
P/S ratio (TTM) P/S ratio 1.57
P/B ratio (TTM) P/B ratio 1.47
Dividend yield 3.74%
Last dividend (FY25) JPY160.00
Revenue growth (TTM) Revenue growth -0.80%
Revenue (TTM) Revenue JPY753.22b
EBIT (operating result TTM) EBIT JPY35.44b
Free Cash Flow (TTM) Free Cash Flow JPY19.41b
Cash position JPY268.61b
EPS (TTM) EPS JPY143.31
P/E forward 26.22
P/S forward 1.55
EV/Sales forward 1.47
Show more

Is Eisai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Eisai Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Eisai forecast:

5x Buy
38%
6x Hold
46%
2x Sell
15%

Analyst Opinions

13 Analysts have issued a Eisai forecast:

Buy
38%
Hold
46%
Sell
15%

Financial data from Eisai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
753,222 753,222
1% 1%
100%
- Direct Costs 157,255 157,255
5% 5%
21%
595,967 595,967
0% 0%
79%
- Selling and Administrative Expenses 352,604 352,604
11% 11%
47%
- Research and Development Expense 168,009 168,009
4% 4%
22%
75,354 75,354
26% 26%
10%
- Depreciation and Amortization 39,910 39,910
0% 0%
5%
EBIT (Operating Income) EBIT 35,444 35,444
43% 43%
5%
Net Profit 40,971 40,971
15% 15%
5%

In millions JPY.

Don't miss a Thing! We will send you all news about Eisai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Haruo Naito
Employees 11,067
Founded 1936
Website www.eisai.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today